GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » DeferredTaxAndRevenue

Bluemtec Co (XKRX:439580) DeferredTaxAndRevenue : ₩0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Bluemtec Co's current deferred tax and revenue for the quarter that ended in Mar. 2024 was ₩0 Mil.

Bluemtec Co DeferredTaxAndRevenue Historical Data

The historical data trend for Bluemtec Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co DeferredTaxAndRevenue Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
DeferredTaxAndRevenue
- - -

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

Bluemtec Co DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bluemtec Co (XKRX:439580) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines